Researchers from the University of Manchester sought to understand whether the season of administration of immunotherapy ...

The addition of PD-1 inhibitors to first-line treatment with transarterial chemoembolization (TACE) plus lenvatinib for ...

Underserved communities, already facing higher asthma prevalence due to social determinants of health, are disproportionately ...

Research highlighted the pivotal role of P2RX7 in driving inflammatory and fibrotic processes in idiopathic pulmonary ...

FoundationOne Liquid CDx can be used to identify niraparib and abiraterone acetate eligibility in patients with metastatic ...

Digital twin technology could personalize treatment for pulmonary hypertension, according to a recent study.

Sindhuja Kadambi, MD, MS, University of Rochester Medical Center, discussed in detail the unique considerations necessary for ...

Investigators compared cost-effectiveness of the KRAS inhibitor sotorasib against the taxane docetaxel in the second line for ...

e-Cigarette users may be less likely to undergo lung cancer screening, study reveals. "Emerging research suggests that ...

Michael Thorpy, MD, professor of neurology, Albert Einstein College of Medicine, discusses the hopeful future of treatment in ...

Looking towards the future, what advancements do you anticipate in the treatment landscape for PNH and other ...

In a recently published systematic review, researchers determined that VEXAS (vacuoles, E1 enzyme, X-linked, autoinflammatory ...